Advancing Colorectal Cancer Diagnosis with AI-Powered Breathomics: Navigating Challenges and Future Directions.
ONCOSCREEN
artificial intelligence
automated diagnosis
breathomics
colorectal cancer
machine learning
manifold learning
validation
volatile organic compounds
Journal
Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402
Informations de publication
Date de publication:
15 Dec 2023
15 Dec 2023
Historique:
received:
10
11
2023
revised:
12
12
2023
accepted:
13
12
2023
medline:
22
12
2023
pubmed:
22
12
2023
entrez:
22
12
2023
Statut:
epublish
Résumé
Early detection of colorectal cancer is crucial for improving outcomes and reducing mortality. While there is strong evidence of effectiveness, currently adopted screening methods present several shortcomings which negatively impact the detection of early stage carcinogenesis, including low uptake due to patient discomfort. As a result, developing novel, non-invasive alternatives is an important research priority. Recent advancements in the field of breathomics, the study of breath composition and analysis, have paved the way for new avenues for non-invasive cancer detection and effective monitoring. Harnessing the utility of Volatile Organic Compounds in exhaled breath, breathomics has the potential to disrupt colorectal cancer screening practices. Our goal is to outline key research efforts in this area focusing on machine learning methods used for the analysis of breathomics data, highlight challenges involved in artificial intelligence application in this context, and suggest possible future directions which are currently considered within the framework of the European project ONCOSCREEN.
Identifiants
pubmed: 38132257
pii: diagnostics13243673
doi: 10.3390/diagnostics13243673
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Subventions
Organisme : European Union's Horizon Europe research and innovation programme
ID : 101097036 (ONCOSCREEN)